Progression of Macular Ischemia Following Intravitreal Bevacizumab
Progression of Macular Ischemia Following Intravitreal Bevacizumab
复制标题
DOI：
10.3928/15428877-20090430-17
复制
发表时间：
2009-05-01
影响因子：
--
通讯作者：
Do, Diana V.
中科院分区：
文献类型：
--
作者：
Sabet-Peyman, E. Jason;Heussen, Florian M. A.;Do, Diana V.
一名患有双侧闭塞性视网膜血管炎和黄斑缺血的37岁女性接受玻璃体内贝伐单抗治疗左眼视盘快速进行性新生血管形成和玻璃体出血。治疗后一周，她出现中心暗点，荧光素血管造影显示治疗眼的视网膜旁毛细血管脱落增加和进行性黄斑缺血。[眼科手术激光成像2009;40：316-318。]
A 37-year-old woman with bilateral obliterative retinal vasculitis and macular ischemia received intravitreal bevacizumab for rapidly progressive neovascularization of the optic disc and vitreous hemorrhage in the left eye. One week after treatment, she presented with central scotoma and fluorescein angiography revealed increased parafoveal capillary dropout and progressive macular ischemia in the treated eye. [Ophthalmic Surg Lasers Imaging 2009;40:316-318.]